In a significant shift within the pharmaceutical and longevity sectors, Rubedo Life Sciences, under the leadership of CEO Dr. Frederick…
Read More
Evogene, Systasy and LMU University Hospital Munich team up on AI-driven drug discovery for inflammatory diseases
A groundbreaking international collaboration, bolstered by a prestigious pan-European EUREKA grant, has been officially announced, aiming to pioneer the development…
Read More
Inflammatory Remodeling of the Bone Marrow Microenvironment Identified as a Precursor to Myeloid Malignancies
The human bone marrow is a site of frantic, precision-engineered biological activity, responsible for the generation of millions of new…
Read MoreYOU MAY HAVE MISSED
